Microsize is the largest independent pharmaceutical micronization business in North America, and a pioneer in enhancing the dissolution and bioavailability of Active Pharmaceutical Ingredients (APIs). The company has the experience and capabilities to rapidly develop, scale-up, and process APIs and excipients ranging from grams to multi-metric tons, including highly potent compounds. We are THE partner of choice from small biotechs to big pharma, recognized for our speed, responsiveness, and high customer-touch business model. When it comes to your toughest dissolution and bioavailability challenges, Think BIG…….Think Microsize. Operating from over 100,000sqft, our FDA-inspected GMP facilities comprise an R&D center, analytical development and QC laboratories, multiple manufacturing suites, and large GMP warehousing. Capabilities include handling highly potent compounds (“HPAPI’s”) in both hard wall, and flexible, single-use disposable containment systems. Microsize world-class facilities have seen significant recent investments in containment technologies, Quality Management Systems, and analytical capabilities. At Microsize, we bring the best of both worlds: providing the high customer-touch, flexibility, and nimbleness of a smaller organization, COMBINED WITH the world-class facilities, quality systems, and capabilities you’d come to expect from a larger global CDMO.